Charles Sermon's most recent trade in Mereo Biopharma Group Plc - ADR was a trade of 262,000 Share Options (Right to buy) done . Disclosure was reported to the exchange on Jan. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 262,000 | 262,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Sale of securities on an exchange or to another person at price $ 4.22 per share. | 12 Sep 2024 | 20,946 | 219,061 | - | 4.2 | 88,413 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Sale of securities on an exchange or to another person at price $ 4.47 per share. | 12 Sep 2024 | 9,980 | 240,007 | - | 4.5 | 44,638 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 65,600 | 249,987 | - | 0 | American Depositary Shares representing Ordinary Shares | |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 65,600 | 0 | - | - | Performance Based Restricted Stock Unit | |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 25 Jun 2024 | 32,187 | 184,387 | - | 3.4 | 109,217 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Sale of securities on an exchange or to another person at price $ 3.69 per share. | 25 Jun 2024 | 14,202 | 216,574 | - | 3.7 | 52,461 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 98,400 | 65,600 | - | - | Performance Based Restricted Stock Unit | |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2024 | 98,400 | 230,776 | - | 0 | American Depositary Shares representing Ordinary Shares | |
| Mereo Biopharma Group Plc ... | Charles Sermon | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 245,000 | 245,000 | - | - | Share Options (Right to buy) |